The U.S. Chamber of Commerce is rolling out a six-figure ad blitz to provide backup for key Republican lawmakers for their ...

Oxy was different, according to the army of sales reps Purdue sent out across the country ... In 2004, Oregon and several other states began investigating Purdue Pharma following media accounts ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and criminality.

Under the instructions of executives, its reps claimed that fentanyl was non-addicting — a more outrageous and dangerous sales pitch than any of Purdue’s.” This isn’t sensationalism.

And a big part of that is down to that direct marketing approach that Arthur Sackler had perfected with other pharma companies. Purdue employed hundreds of sales reps to go around the country ...

What Happened: Purdue Pharma developed and aggressively marketed OxyContin starting in the 1990s via medical sales reps whose job was to convince doctors to prescribe more of their drug.

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...